DAY 1, Thursday - 19th March 2020
| DAY 1, Thursday - 19th March 2020 | ||
| TIME | PROGRAM | SPEAKER |
| 07:00 - 08:00 | Registration | |
| 08:00 - 09:30 | Nursing Workshop | |
| 07:45 – 08:00 | Welcome Note | |
| 08:00 – 08:15 | Introduction to pediatric hematology | Khalid Al Habaybia |
| 08:15 – 08:40 | CAR T cell, the future for hematology patients | Mahmoud Hasan |
| 08:40 – 09:00 | Case presentation of ALL patients (Besponsa (Inotuzumab Ozogamicin) | Tahani Dweikat |
| 09:00 – 09:30 | Management of CRS in acute refractory ALL patients | Khaled Al Qawasmeh |
| 09:30 - 10:00 | Coffee Break | |
| 10:00 - 11:30 | Nursing Workshop | |
| 10:00 – 10:20 | Acute Lymphoblastic Leukemia in Adolescents and Young Adults | Mariam M. I. Aiash |
| 10:20 – 10:40 | Venetoclax and decitabine OR azacitidine in the treatment of AML patients | Mohammad Saleh |
| 10:40 – 11:00 | Impact of a Pain Management Program on Oncology\ Hematology Nurses' Knowledge | Nezar Ahmed Salim |
| 11:00 – 11:20 | Knowledge and Attitudes towards the Palliative Care among health care providers at Dubai hospital. | Hasan Ahmad Abu Nigim |
| 11:20 - 11:30 | Q&A | |
| 11:30 - 11:50 | Industry Symposium | |
| 11:50 - 12:10 | Industry Symposium by Sobi | |
| 12:10 - 12:30 | Industry Symposium by Sandoz Aggressive DLBCL & Biosimilar medicine- What’s new? | Ahmed Ibrahim |
| 12:30 - 13:30 | Opening Ceremony | |
| 13:30 - 14:30 | Lunch | |
| 14:30 - 16:00 | Session 1 - Acute Leukemia/MPN I Chairperson: Mahmoud Marashi |
|
| 14:30 - 14:50 | Diagnostic workup of AML, what is relevant in 2020 | Martin Tallman |
| 14:50 - 15:10 | Diagnostic workup of ALL /risk stratification | Daniel Deangelo |
| 15:10 - 15:30 | How I treat AML in 2020 | Martin Tallman |
| 15:30 - 15:50 | Diagnostic workup of MPN | Mrinal Patnaik |
| 15:50 - 16:00 | Q&A | |
| 16:00 - 16:30 | Coffee Break | |
| June 26, 1900 | Session 2 - Acute Leukemia/MPN II Chairperson: Amna El Mehairi, S. Hashmi |
|
| 16:30 - 16:50 | Current treatment approach in ET, PV and MF | Mrinal Patnaik |
| 16:50 - 17:10 | Novel immunotherapies in ALL, what is their role and how to manage toxicities | Daniel Deangelo |
| 17:10 - 17:30 | How to choose the right TKI in CML | Mrinal Patnaik |
| 17:30 - 17:40 | Q&A | |
DAY 2, Friday - 20th March 2020
| DAY 2, Friday - 20th March 2020 | ||
| TIME | PROGRAM | SPEAKER |
| 08:00 - 08:30 | Industry Symposium by Sobi | |
| 08:30 - 10:00 | Session 3 - Plasma Cell Dyscrasia Chairperson: Rehab Alblooshi, Hassan Al Yaseen |
|
| 08:30 - 08:50 | Diagnostic workup of Myeloma in 2020, what is relevant and its impact in management | Jes ús San Miguel |
| 08:50 - 09:10 | Diagnosis and management of AL Amyloidosis in 2020 | Joseph Mikhael |
| 09:10 - 09:30 | How I treat myeloma in young and elderly/frail | Jes ús San Miguel |
| 09:30 - 09:50 | How I diagnose and treat Waldenstr ӧ m Macroglobulinemia | Joseph Mikhael |
| 09:50 - 10:00 | Q&A | |
| 10:00 - 10:30 | Coffee Break | |
| 10:30 - 12:00 | Session 4 - Lymphoproliferative Neoplasm I Chairperson: Arif Alam, Mahmoud Al Jurf |
|
| 10:30 - 10:50 | Double Hit Lymphoma | Ranjana Advani |
| 10:50 - 11:10 | Follicular lymphoma; have we made progress ? | Thomas Witzig |
| 11:10 - 11:30 | Diagnostic workup in HLH | Paul Laros ée |
| 11:30 - 11:50 | Management of high risk hodgkin lymphoma; beyond ABVD | Ranjana Advani |
| 11:50 - 12:00 | Q&A | |
| 12:00 - 13:30 | Friday Prayers & Lunch | |
| 13:30 - 13:50 | Industry Symposium by Takeda | |
| 13:50 - 14:10 | Industry Symposium by Novartis | |
| 14:10 - 15:40 | Session 5 - Lymphoproliferative Neoplasm II Chairperson: Faraz Khan, Shabeeha Rana |
|
| 14:10 - 14:30 | Update in aggressive lymphoma; is it the time to incorporate new agents? | Thomas Witzig |
| 14:30 - 14:50 | How I treat HLH | Paul Laros ée |
| 14:50 - 15:35 | ASH Highlights | Ranjana Advani |
| 15:35 - 15:45 | Q&A | |
| 15:45 - 16:20 | Coffee Break | |
| 16:20 - 18:00 | Session 6 - Lymphoma/Transplant | |
| 16:20 - 16:40 | How I treat Primary CNS lymphoma in 2020 | Thomas Witzig |
| 16:40 - 17:00 | Cutaneous T-Cell Lymphoma | Kyowa Kirin |
| 17:00 - 17:20 | GVHD | |
| 17:20 - 17:50 | Tumour Board (Management of lymphoma in pregnancy by Dr. Ranjana + other lymphoma faculty) | |
| 17:50 - 18:00 | Q&A | |
DAY 3, Saturday - 21st March 2020
| DAY 3, Saturday - 21st March 2020 | |||
| TIME | PROGRAM | SPEAKER | |
| 08:00 - 08:30 | Industry Symposium by Apopharma New Paediatric Data | Antonis Kattamis | |
| 08:30 - 09:00 | Industry Symposium by Sanofi Were you Expecting Leukemia? | Irene Motta | |
| 09:00 - 10:00 | Session 7 - Oral Abstracts Session Chairperson: Khawla Belhoul, Salam Al kindi |
||
| 10:00 - 10:30 | Coffee Break | ||
| 10:30 - 12:00 | Session 8 - Hemostasis & Thrombosis Chairperson: Nevine Kassam, A Al-Momen |
||
| 10:30 - 10:50 | VWD; case based approach in diagnosis and management | Alice Ma | |
| 10:50 - 11:10 | How I treat HIT; role of DOACs and high dose IVIG | Theodore Warkentin | |
| 11:10 - 11:30 | Coagulation factor replacement in hemophilia; what is their place in the era of novel therapies | Alice Ma | |
| 11:30 - 11:50 | Role of shock liver in the pathogenesis of ischemic limb injuries in critically ill patients in DIC | Theodore Warkentin | |
| 11:50 - 12:00 | Q&A | ||
| 12:00 - 13:00 | Lunch | ||
| 13:00 - 14:30 | Session 9 - Bone Marrow Failure Chairperson: Maryam Darwish, Abdulhakim Al Rawas |
||
| 13:00 - 13:20 | White cell disorders; How to approach neutropenia in the outpatient setting | Neal Young | |
| 13:20 - 13:40 | Challenging cases in aplastic anemia | Neal Young | |
| 13:40 - 13:50 | Q&A | ||
| 13:50 - 14:30 | Session 10 - Sickle Cell | Parallel Session | |
| 13:50 - 14:20 | Sickle cell disease: Emerging disease-modifying therapies | Miguel Abboud | Amgen |
| 14:20 - 14:30 | Q&A | ||
| 14:30 - 14:50 | Industry Symposium by Novonordisk | ||
| 14:50 - 15:10 | Industry Symposium by Astra Zeneca | ||
| 15:10 - 15:30 | Industry Symposium by Roche Finding The Achilles Heel: Role of Comprehensive Genomic in Haematological Malignancies | Ziad Perwani | |